Brief: India's Ajanta Pharma launches clonidine hydrochloride extended release tablets in U.S.
Nov 21 (Reuters) - Ajanta Pharma Ltd AJPH.NS :
* Ajanta Pharma announces approval & launch of clonidine
hydrochloride extended release tablets
* Says tablets launched in U.S. via co's unit Ajanta Pharma
USA
Inc
Source text - http://bit.ly/2mOxZjC
Further company coverage: AJPH.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility